target protein Applications
-
Investors - Akrotome FIRE
Advances in diagnostic methods have enabled the detection of cancer at the earliest stages when the chances for successful intervention are highest. For many solid tumors, the best chance for a cure is surgery. A surgical cure depends upon the complete removal of all cancer tissue from a patient (a “complete resection”). The main challenge of this approach is that it is very difficult for a surgeon to determine where diseased tissue ends and healthy tissue begins. The result is that many surgical ...
By Akrotome Imaging, Inc. based in Cleveland, OHIO (USA).
-
Clinicians - FIRE – A Flexible and Precise Molecular Probe Platform Expressly Designed for Cancer Surgeons
A critical factor in ensuring complete resection of a solid cancer tumor is the ability to determine where diseased tissue ends and healthy tissue begins. Our research, as well as our clinical collaborators, confirm that there is a pressing unmet clinical need: the ability to rapidly and globally assess the status of marginal tissue adjacent to a tumor while the patient is in the ...
By Akrotome Imaging, Inc. based in Cleveland, OHIO (USA).
-
Proteome array screening solutions for antibody specificity profiling sector
, with typical antibody QC involving evidence of binding to the intended target, while neglecting potential ...
By Cambridge Protein Arrays Ltd. (CPAP) based in Cambridge, UNITED KINGDOM.
-
Proteome array screening solutions for autoantibody screening sector
are present in the blood of all healthy individuals. However, when directed at high levels against ...
By Cambridge Protein Arrays Ltd. (CPAP) based in Cambridge, UNITED KINGDOM.
-
Affilin - Precision Targeting Technology for Cellular Therapies
, they were confirmed to be functionally expressed on the effector cell surface, mediate target ...
By Navigo Proteins GmbH based in Halle, GERMANY.
-
Affilin - Precision Targeting Technology for Protein Drug Conjugates
Several of the Navigo-created, ready-to-go Affilin molecules against solid tumor ...
By Navigo Proteins GmbH based in Halle, GERMANY.
-
Erythromycin A 9,11-Imino Ether
protein synthesis by targeting the 53S ribosomal subunit. ...
By BOC Sciences based in Shirley, NEW YORK (USA).
-
Antibody Discovery
as it requires the development of hybridomas and the engineering of antibodies to recognize a specific ...
By NanoCellect Biomedical, Inc. based in San Diego, CALIFORNIA (USA).
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you